Scholarly Index
Antje Tockhorn‐Heidenreich
Eli Lilly (United States); 836 total citations; 53 total publications; best world rank #486
Eli Lilly (United States)
836Total citations
53Total publications
14H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Migraine and Headache Studies | 2021-2025 | 486 | US 123 | 85.35 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 855 | US 206 | 59.24 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 771 | US 181 | 32.97 |